
    
      The aim of the non-interventional study is to document efficacy and tolerability of
      rasagiline as a combination therapy in patients with wearing-off-/End-of-dose fluctuations
      and the effect of rasagiline on individual wearing-off symptoms, recognized by wearing-off
      questionnaire 32 (WOQ-32).
    
  